Bacterial Coinfection in Critically Ill Patients With COVID-19

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Microbiology

Background:

• Patients in intensive care units (ICUs) with coronavirus disease 2019 (COVID-19) face a higher risk of secondary bacterial infections.
• Common coinfections include ventilator-associated pneumonia (VAP), bloodstream infections (BSI), and catheter-associated urinary tract infections (CA-UTI).

Purpose of the Study:

• To determine the prevalence, identify risk factors, and characterize the spectrum of bacterial coinfections in COVID-19 patients admitted to the ICU.
• To compare findings with existing literature and reviews.

Main Methods:

• A single-center retrospective cohort study analyzed data from 201 COVID-19 patients admitted to the University Clinical Intensive Care Hospital in Bialystok, Poland.
• Data collected between March 2020 and July 2021 included coinfection prevalence, risk factors, and causative agents.

Main Results:

• Bacterial coinfections were prevalent, affecting 70% of the studied COVID-19 ICU patients.
• Ventilator-associated pneumonia (VAP) was the most common (47.5% of coinfections), followed by BSI and CA-UTI.
• Prolonged mechanical ventilation (mean 13.3 days) and extended ICU stays (mean 15.3 days) were significant risk factors.
• Klebsiella pneumoniae and Staphylococcus aureus were predominant pathogens. Klebsiella pneumoniae producing extended-spectrum beta-lactamases (ESBL) was frequently isolated (>48h ICU admission).

Conclusions:

• Bacterial coinfections are a significant concern for COVID-19 patients in the ICU.
• Effective management requires vigilant monitoring, robust antimicrobial stewardship, and stringent infection prevention strategies.
• Addressing these coinfections is crucial for improving patient outcomes in the ICU setting.